JPMorgan Chase & Co. Raises Stock Position in Medical Properties Trust, Inc. (NYSE:MPW)

JPMorgan Chase & Co. grew its stake in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 4.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,782,664 shares of the real estate investment trust’s stock after buying an additional 77,879 shares during the period. JPMorgan Chase & Co. owned 0.30% of Medical Properties Trust worth $7,042,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in MPW. Allworth Financial LP boosted its stake in Medical Properties Trust by 230.4% during the fourth quarter. Allworth Financial LP now owns 6,082 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 4,241 shares during the period. RFG Advisory LLC purchased a new position in Medical Properties Trust during the fourth quarter valued at approximately $40,000. Silver Oak Securities Incorporated purchased a new position in shares of Medical Properties Trust in the 4th quarter valued at $40,000. Verus Capital Partners LLC purchased a new position in Medical Properties Trust in the fourth quarter valued at about $40,000. Finally, RS Crum Inc. bought a new position in shares of Medical Properties Trust during the 4th quarter worth approximately $40,000. 71.79% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. StockNews.com raised shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Monday, March 3rd. Wells Fargo & Company boosted their price target on Medical Properties Trust from $4.00 to $5.00 and gave the company an “underweight” rating in a report on Monday, March 10th. Royal Bank of Canada raised their target price on Medical Properties Trust from $4.00 to $5.00 and gave the company a “sector perform” rating in a research report on Monday, March 10th. Truist Financial decreased their price objective on shares of Medical Properties Trust from $6.00 to $4.00 and set a “hold” rating on the stock in a report on Thursday, December 19th. Finally, BNP Paribas upgraded shares of Medical Properties Trust from a “neutral” rating to an “outperform” rating and increased their target price for the company from $5.00 to $9.00 in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $5.64.

Medical Properties Trust Stock Down 1.1 %

MPW opened at $5.38 on Thursday. The business has a 50 day simple moving average of $5.48 and a 200-day simple moving average of $4.80. Medical Properties Trust, Inc. has a 12 month low of $3.51 and a 12 month high of $6.55. The stock has a market capitalization of $3.23 billion, a P/E ratio of -1.27, a P/E/G ratio of 1.01 and a beta of 1.27. The company has a debt-to-equity ratio of 1.69, a current ratio of 2.38 and a quick ratio of 2.38.

Medical Properties Trust Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, April 10th. Shareholders of record on Monday, March 10th were given a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 5.95%. The ex-dividend date was Monday, March 10th. Medical Properties Trust’s payout ratio is currently -8.42%.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.